-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Agios Pharmaceuticals, Raises Price Target to $46

Benzinga·07/07/2026 11:02:32
Listen to the news
B of A Securities analyst Alec Stranahan maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Buy and raises the price target from $40 to $46.